Tchaikapharma High Quality Medicines AD (BUL:THQM)

BUL:THQM Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.06	0.61	0.07	0.03	0.07	0.03
Cash & Short-Term Investments	0.06	0.61	0.07	0.03	0.07	0.03
Cash Growth	5.30%	746.08%	133.94%	-57.74%	149.03%	-10.90%
Accounts Receivable	39.15	37.68	33.08	31.17	30.03	29.13
Other Receivables	0.19	0.19	0.07	0.01	0.02	0.02
Receivables	39.34	37.87	33.15	31.18	30.05	29.16
Inventory	9.15	9.17	8.13	7.31	6.89	5.8
Prepaid Expenses	-	-	-	0.04	0.04	0.03
Other Current Assets	2.61	2.62	3.22	2.78	1.65	1.11
Total Current Assets	51.15	50.26	44.57	41.34	38.7	36.13
Property, Plant & Equipment	17.25	17.9	17.07	16.91	18.05	19.47
Long-Term Investments	0.03	-	-	0.01	-	-
Other Intangible Assets	1.95	1.84	1.45	1.82	1.92	1.76
Long-Term Accounts Receivable	2.6	2.6	2.77	2.55	2.59	2.7
Total Assets	72.99	72.61	65.87	62.63	61.27	60.06

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.33	4.86	1.71	2.44	2.15	2.03
Accrued Expenses	0.7	0.69	0.62	-	0.42	0.44
Short-Term Debt	4	4.75	5.02	5.01	5	5
Current Portion of Leases	0.44	0.48	0.34	0.26	0.32	0.51
Current Income Taxes Payable	-	0.52	0.06	0.12	0.08	0.06
Other Current Liabilities	0.1	0.04	0.93	-	0.02	0.02
Total Current Liabilities	9.57	11.34	8.67	7.83	8	8.05
Long-Term Leases	0.57	0.79	0.35	0.45	0.72	0.88
Pension & Post-Retirement Benefits	0.18	0.18	0.14	0.1	0.1	0.08
Long-Term Deferred Tax Liabilities	0.64	0.64	0.61	0.57	0.53	0.53
Total Liabilities	10.96	12.95	9.77	8.95	9.34	9.53

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	49.03	49.06	47.06	43.2	43.19	43.21
Retained Earnings	5.47	10.6	9.04	10.48	8.73	7.32
Comprehensive Income & Other	7.53	-	-	-	-	-
Shareholders' Equity	62.03	59.66	56.1	53.69	51.93	50.53
Total Liabilities & Equity	72.99	72.61	65.87	62.63	61.27	60.06

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.02	6.02	5.7	5.71	6.03	6.39
Net Cash (Debt)	-4.96	-5.41	-5.63	-5.68	-5.96	-6.36
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.05	-0.05	-0.06	-0.06	-0.06	-0.06
Filing Date Shares Outstanding	101.3	101.3	101.3	97.99	97.99	97.99
Total Common Shares Outstanding	101.3	101.3	101.3	97.99	97.99	97.99
Working Capital	41.58	38.92	35.9	33.52	30.7	28.08
Book Value Per Share	0.61	0.59	0.55	0.55	0.53	0.52
Tangible Book Value	60.08	57.81	54.65	51.87	50	48.77
Tangible Book Value Per Share	0.59	0.57	0.54	0.53	0.51	0.50
Land	-	-	-	6.83	6.83	6.83
Buildings	-	-	-	6.74	6.66	6.36
Machinery	-	-	-	20.02	19.9	19.49

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error